⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AMGN News
Amgen Inc
Accord Healthcare Announces Launch of Denosumab∇ - Second Biosimilar in Bone Health USA - English USA - English
prnewswire.com
AMGN
Next-Generation Biologics and Biosimilars Market to Hit 251.13 billion Dollars by 2033 - Strategic Revenue Insights (SRI)
prnewswire.com
AMGN
PFE
RHHBY
NVS
MRK
LLY
Chronic Kidney Disease Anemia Market Opportunity Assessment and Forecasts 2024-2034: Drug Costs, Safety Improvements, ESA Alternatives, and Enhanced Clinical Trial Design
globenewswire.com
AMGN
JNJ
GSK
ABBVIE
AKORN
AVROBIO
BAYER
MERCK
COSM
ROCHE
CHMP
SHP
ASTELLAS
Familial Hypercholesterolemia Market Intelligence Report 2025-2035 Featuring Regeneron, Amgen, Esperion, Aegerion, Novartis and Other Key Players - Precision Medicine Fuels Personalized Treatment Approaches
globenewswire.com
REGN
AMGN
ESPR
ARWR
Antitumor ADC Drugs Market Forecast Shows Strong 12.86% CAGR Through 2035
globenewswire.com
PFE
AZN
DSNKY
GILD
IMMU
REGN
BIIB
BMY
MRK
NVS
AMGN
LLY
JNJ
ABBV
BNTX
SEGN
RHHBY
Takeda
IQV
PE
TSLP Inhibitors and TSLP Receptor Antagonists Competitor Analysis Report 2025: Early R&D in Tezspire Biosimilars Also Offers Growth Avenues
globenewswire.com
AMGN
Rencore extends Series A to USD 15 million to accelerate AI governance growth and international expansion
prnewswire.com
MSFT
AMGN
HON
Comprehensive Psoriasis Industry Assessment 2025-2035 - Asia-Pacific Real-World Evidence Reveals Strengthened and Effective Healthcare Strategies
globenewswire.com
ABBV
AMGN
NVS
JNJ
LLY
2025 Lupus Research Alliance Gala Raises Millions to Bring New Treatments and A Cure
prnewswire.com
IHRT
AMGN
Chronic Heart Failure Clinical Trial Pipeline Shows Potential with Active Contributions from 25+ Key Companies | DelveInsight
globenewswire.com
CYTK
BAYRY
LLY
BCDA
MESO
TNSA
NVO
AZN
BMY
ITCI
JNJ
AMGN
ARWR